Public Profile

Galderma

Galderma, a leading global dermatology company, is headquartered in the United States and operates extensively across Europe, Asia, and Latin America. Founded in 1981, Galderma has established itself as a pioneer in the field of medical and aesthetic dermatology, focusing on innovative solutions for skin health. The company is renowned for its core products, including the Restylane® range of dermal fillers and the Sculptra® aesthetic treatment, which are distinguished by their unique formulations and proven efficacy. Galderma's commitment to research and development has positioned it as a trusted name in the industry, with a strong market presence and notable achievements in advancing dermatological care. With a focus on enhancing skin health and beauty, Galderma continues to lead the way in dermatological innovation.

DitchCarbon Score

How does Galderma's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

26

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Galderma's score of 26 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.

0%

Let us know if this data was useful to you

Galderma's reported carbon emissions

In 2023, Galderma reported total carbon emissions of approximately 340,200 kg CO2e, comprising 7,600 kg CO2e from Scope 1, 5,500 kg CO2e from Scope 2, and a significant 332,100 kg CO2e from Scope 3 emissions. The company has not disclosed any specific reduction targets or initiatives, indicating a potential area for future commitment in climate action. As a global leader in the dermatology sector, Galderma's emissions profile highlights the importance of addressing Scope 3 emissions, which represent the majority of their carbon footprint. The absence of defined reduction strategies suggests that Galderma may need to enhance its climate commitments to align with industry standards and expectations.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

2023
Scope 1
7,600
Scope 2
5,500
Scope 3
332,100

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Galderma's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Galderma is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Galderma is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Verrica Pharmaceuticals Inc.

US
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Novartis

CH
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Hyphens Pharma International Limited

SG
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Merck And Co

US
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Celgene Corporation

US
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Almirall Hermal GmbH

DE
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers